| name | es-ghc-add-nph-to-bbi |
| description | In patients already on a basal bolus insulin (BBI) regimen who develop hyperglycemia while receiving glucocorticoids, consider adding neutral protamine Hagedorn (NPH) insulin to the regimen. Trigger phrases include: "Patient is on BBI, should we add NPH for steroid coverage?" or "Glucocorticoid-associated hyperglycemia on BBI, consider NPH addition." |
Consider adding NPH to existing basal bolus insulin regimen
STEP 1 — Gather Information
Collect: current basal insulin type and dose, prandial insulin schedule, glucocorticoid type, dose, frequency, and timing of administration, recent point-of-care blood glucose (POC-BG) values (especially pre-meal and bedtime), target glucose range (100–180 mg/dL), and any history of hypoglycemia or renal impairment.
STEP 2 — Rule In / Rule Out
Is the patient already on a basal bolus insulin regimen? If yes, proceed to Step 3; if no, consider initiating an NPH-based or BBI regimen per guideline Recommendation 2.1 instead of adding NPH to BBI.
STEP 3 — Classify or Stratify
Stratify by glucocorticoid administration schedule: once daily (e.g., morning), twice daily, or continuous/infrequent bolus. For once. For once-daily GC, plan NPH once daily; for twice-daily GC, consider NPH twice daily; for variable dosing, consider divided NPH doses aligned with GC peaks.
STEP 4 — Decide
Add NPH insulin to the existing BBI regimen: start with a dose of 0.1–0.2 units/kg per NPH dose (or approximately 10% of total daily basal insulin dose per administration) timed to coincide with glucocorticoid administration; monitor POC-BG four times daily and adjust NPH dose by 10–20% based on pre-meal trends to maintain glucose 100–180 mg/dL while avoiding hypoglycemia.
Clinical Guardrails / Mimics / Pitfalls
Do not add NPH if the patient has a history of severe hypoglycemia or is undergoing rapid glucocorticoid taper; avoid NPH when glucocorticoids are abruptly discontinued without taper; do not ignore the need to reduce or discontinue NPH as glucocorticoids are tapered to prevent hypoglycemia; ensure frequent glucose monitoring especially during glucocorticoid peaks and troughs.
Concrete Clinical Example
A 62‑year‑old on BBI (glargine 20 units at bedtime, insulin lispro 5 units with meals) receives prednisone 40 mg each morning and develops hyperglycemia with POC‑BG 210–260 mg/dL; add NPH 10 units each morning, continue basal and prandial insulin, check glucose before meals and at bedtime, titrate NPH upward if glucose remains >180 mg/dL.
Source: Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, https://doi.org/10.1210/clinem/dgac278
